Abdurrahman GENÇ, Kağan ÜÇOK, Ersin GÜNAY, Yücel GÖNÜL, Hatice KARABACAK, Ümit ŞENER, Serkan NURAL, Mehmet ÜNLÜ

8996

Effects of long-acting beta-2 agonist treatment on daily energy balance and body composition in patients with chronic obstructive pulmonary disease

The aim of this study was to investigate the effects of long-acting beta-2 agonist (formoterol) treatment on the resting metabolic rate (RMR), daily physical activity, body composition and anthropometry, nutritional status, and quality of life of patients with chronic obstructive pulmonary disease (COPD). Materials and methods: A total of 30 male patients who were diagnosed with COPD participated in the study. The RMR was determined using an indirect calorimeter, daily physical activity was measured with an accelerometer, and body composition was established by bioelectric impedance analysis. Body circumference and skinfold thickness measurements were carried out. Pulmonary function tests were performed with a spirometer. The 36-item short-form health survey (SF-36) quality of life questionnaire and dietary intake records were obtained from the participants. Following the initial measurements, the patients received a 12-µg formoterol inhaler twice daily for 3 months. At the end of the 3 months, all of the measurements and questionnaires were collected once again. Results: Although the RMR, daily physical activity, body mass index, body fat percentage and fat distribution measurements, dietary intake record, and quality of life questionnaire scores were not statistically different before and after treatment in the patients with COPD, an increase in pulmonary function tests (forced expiratory volume in 1 s and peak expiratory flow) was recorded. Conclusion: Our results suggest that 3-month long-acting beta-2 agonist treatment does not change the daily energy balance and body composition in male COPD patients.
Anahtar Kelimeler:

Key words: Chronic obstructive pulmonary disease, beta-2 agonist, resting metabolic rate, daily physical activity, body fat, anthropometry

Effects of long-acting beta-2 agonist treatment on daily energy balance and body composition in patients with chronic obstructive pulmonary disease

The aim of this study was to investigate the effects of long-acting beta-2 agonist (formoterol) treatment on the resting metabolic rate (RMR), daily physical activity, body composition and anthropometry, nutritional status, and quality of life of patients with chronic obstructive pulmonary disease (COPD). Materials and methods: A total of 30 male patients who were diagnosed with COPD participated in the study. The RMR was determined using an indirect calorimeter, daily physical activity was measured with an accelerometer, and body composition was established by bioelectric impedance analysis. Body circumference and skinfold thickness measurements were carried out. Pulmonary function tests were performed with a spirometer. The 36-item short-form health survey (SF-36) quality of life questionnaire and dietary intake records were obtained from the participants. Following the initial measurements, the patients received a 12-µg formoterol inhaler twice daily for 3 months. At the end of the 3 months, all of the measurements and questionnaires were collected once again. Results: Although the RMR, daily physical activity, body mass index, body fat percentage and fat distribution measurements, dietary intake record, and quality of life questionnaire scores were not statistically different before and after treatment in the patients with COPD, an increase in pulmonary function tests (forced expiratory volume in 1 s and peak expiratory flow) was recorded. Conclusion: Our results suggest that 3-month long-acting beta-2 agonist treatment does not change the daily energy balance and body composition in male COPD patients.
Keywords:

Key words: Chronic obstructive pulmonary disease, beta-2 agonist, resting metabolic rate, daily physical activity, body fat, anthropometry,

PDF
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Circulating levels of IGF-I and IGFBP-3 in gastric cancer

Konca ALTINKAYNAK, Memet BİLİCİ, Nuri BAKAN, Fatih AKÇAY

Dietary boron intake does not change the ischemic tolerance and preconditioning response in isoproterenol-induced myocardial injury in healthy rats

Mehmet Fatih KARAKAŞ, Mustafa KURT, Uğur ARSLANTAŞ, Göktürk İPEK, Esra KARAKAŞ, Emine BİLEN, Hüsamettin ERDAMAR

Descending necrotizing mediastinitis: increased mortality due to delayed presentation

Mehmet Muharrem EROL, Ahmet URAL, Hüseyin MELEK, Ahmet Sami BAYRAM, Celal TEKİNBAŞ, Cengiz GEBİTEKİN

Effects of long-acting beta-2 agonist treatment on daily energy balance and body composition in patients with chronic obstructive pulmonary disease

Abdurrahman GENÇ, Kağan ÜÇOK, Ersin GÜNAY, Yücel GÖNÜL, Hatice KARABACAK, Ümit ŞENER, Serkan NURAL, Mehmet ÜNLÜ

Minimum inhibitory and minimum bactericidal concentrations of boron compounds against several bacterial strains

Murat Tolga YILMAZ

Right diaphragmatic lipoma: report of five cases and review of the literature

Yener AYDIN, Mustafa Esat YAMAÇ, Ali Bilal ULAŞ, Habib BİLEN, Atila EROĞLU

Evaluation of the treatment results of laryngeal carcinoma: our experience over 10 years

Erkan KARATAŞ, Elif BAYSAL, Cengiz DURUCU, Tekin BAĞLAM, Yıldırım Ahmet BAYAZIT, Muzaffer KANLIKAMA

Effects of lycopene on plasma glucose, insulin levels, oxidative stress, and body weights of streptozotocin-induced diabetic rats

Muhsin AYDIN, Sefa ÇELİK

Primary anorectal malignant melanoma: rare but highly lethal malignancy

Özlem SÖNMEZ, Ümmügül ÜYETÜRK, Kaan HELVACI, İbrahim TÜRKER, Fahriye Tuğba KÖŞ, Lütfi DOĞAN, Burçin BUDAKOĞLU, Ülkü YALÇINTAŞ ARSLAN, Ömür Berna ÇAKMAK ÖKSÜZOĞLU

Effect of intravitreal octreotide acetate injection on retinal neovascularization, morphology, and apoptotic cell death in an oxygen-induced retinopathy mouse model

Fatma Selin KAYA, İmren AKKOYUN, Asuman Nihan HABERAL REYHAN, Attila DAĞDEVİREN, Gürsel YILMAZ, Sibel OTO, Yonca AKOVA